by According to latest research report published by Vision Research Reports, the global Intraocular Lens market is projected to reach $6.1 billion by 2030 from $3.9 billion in 2020 at a CAGR of 4.7% during, Intraocular Lens Market Report provides crucial industry insights that will help your business grow.
Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/39136
Growth Factors
The rise in the geriatric and diabetic population, which is prone to develop cataracts and other visual disorders, is expected to foster market growth. In addition, rising awareness regarding visual disorders, increase in healthcare spending, and government support to improve the healthcare infrastructure are some of the significant factors boosting the growth of the market.
Despite the drop in sales of the intraocular lens during the pandemic, the market is recovering and is expected to grow steadily during the forecast period. Factors such as a rise in the incidence of cataracts and an increase in the number of diagnosed cases of blindness are major factors that are boosting the growth of the market. In addition, increasing awareness regarding cataracts and a rise in healthcare spending are expected to drive the sales of intraocular lenses.
Report Coverage
| Report Scope | Details |
| Market Size | US$ 6.1 billion by 2030 |
| Growth Rate | CAGR of 4.7% From 2022 to 2030 |
| Largest Market | North America |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Product, End use |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Mentioned | Alcon, Inc.; Johnson and Johnson Vision Care, Inc.; Bausch & Lomb Incorporated; Carl Zeiss Meditec AG (ZEISS International); Rayner; EyeKon Medical, Inc.; Lenstec, Inc.; HumanOptics AG; STAAR Surgical Company; HOYA CORPORATION |
By Product Analysis
The multifocal intraocular lens segment held the largest revenue share of over 50.0% in 2021 owing to the benefits that multifocal intraocular lenses offer including high precision and improved visualization.
These vision zones help the patients to see far, intermediate, and near distances efficiently with improved and higher precision as compared to traditional mono-focal lenses.
The toric intraocular lens segment emerged as the second-largest segment in 2021 and is expected to witness lucrative growth over the forecast period as it is beneficial specifically for patients with moderate to high astigmatism.
Toric intraocular lenses are specifically designed to treat such patients. Furthermore, toric IOLs are designed to eliminate the need for incision implants required traditionally during astigmatism surgical procedures, thereby increasing its preference among individuals.
By End-use Analysis
The hospitals segment dominated the market with a revenue share of over 50.0% in 2021 owing to the majority of cataract and vision repair surgeries being performed in the hospitals. In the developing regions, there is a substantial increase in individual ophthalmic clinics.
Government and non-government organizations are focusing on carrying out research in the ophthalmic domain. This is with an aim to develop technologically advanced products and intraocular lenses that represent the potential to serve the needs of the patient population in a much more effective manner.
By Regional Analysis
North America dominated the market for intraocular lenses in 2021 with a revenue share of over 35.0%. It is expected to continue being the dominant region throughout the forecast period. This is due to the rising incidence of cataracts and other ophthalmic disorders.
Asia Pacific is expected to witness the fastest growth during the forecast period. The presence of a large geriatric and diabetic population, which is prone to cataracts and other ophthalmic disorders, is majorly contributing to the growth of the market in this region.
Key Players
- Alcon, Inc.
- Johnson and Johnson Vision Care, Inc.
- Bausch & Lomb Incorporated
- Carl Zeiss Meditec AG (ZEISS International)
- Rayner
- EyeKon Medical, Inc.
- Lenstec, Inc.
- HumanOptics AG
- STAAR Surgical Company
- HOYA CORPORATION
Market Segmentation
- By Product
- Monofocal Intraocular Lens
- Multifocal Intraocular Lens
- Toric Intraocular Lens
- Accommodative Intraocular Lens
- By End-use
- Hospitals
- Ophthalmic Clinics
- Ambulatory Surgery Centers
- Eye Research Institutes
- Regional
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Asia Pacific
- Japan
- China
- India
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- North America
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Intraocular Lens Market, By Product
7.1. Intraocular Lens Market, by Product, 2021-2030
7.1.1. Monofocal Intraocular Lens
7.1.1.1. Market Revenue and Forecast (2019-2030)
7.1.2. Multifocal Intraocular Lens
7.1.2.1. Market Revenue and Forecast (2019-2030)
7.1.3. Toric Intraocular Lens
7.1.3.1. Market Revenue and Forecast (2019-2030)
7.1.4. Accommodative Intraocular Lens
7.1.4.1. Market Revenue and Forecast (2019-2030)
Chapter 8. Global Intraocular Lens Market, By End-use
8.1. Intraocular Lens Market, by End-use, 2021-2030
8.1.1. Hospitals
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Ophthalmic Clinics
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Ambulatory Surgery Centers
8.1.3.1. Market Revenue and Forecast (2019-2030)
8.1.4. Eye Research Institutes
8.1.4.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Intraocular Lens Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Product (2019-2030)
9.1.2. Market Revenue and Forecast, by End-use (2019-2030)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Product (2019-2030)
9.1.3.2. Market Revenue and Forecast, by End-use (2019-2030)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Product (2019-2030)
9.1.4.2. Market Revenue and Forecast, by End-use (2019-2030)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Product (2019-2030)
9.2.2. Market Revenue and Forecast, by End-use (2019-2030)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Product (2019-2030)
9.2.3.2. Market Revenue and Forecast, by End-use (2019-2030)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Product (2019-2030)
9.2.4.2. Market Revenue and Forecast, by End-use (2019-2030)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Product (2019-2030)
9.2.5.2. Market Revenue and Forecast, by End-use (2019-2030)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Product (2019-2030)
9.2.6.2. Market Revenue and Forecast, by End-use (2019-2030)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Product (2019-2030)
9.3.2. Market Revenue and Forecast, by End-use (2019-2030)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Product (2019-2030)
9.3.3.2. Market Revenue and Forecast, by End-use (2019-2030)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Product (2019-2030)
9.3.4.2. Market Revenue and Forecast, by End-use (2019-2030)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Product (2019-2030)
9.3.5.2. Market Revenue and Forecast, by End-use (2019-2030)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Product (2019-2030)
9.3.6.2. Market Revenue and Forecast, by End-use (2019-2030)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Product (2019-2030)
9.4.2. Market Revenue and Forecast, by End-use (2019-2030)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Product (2019-2030)
9.4.3.2. Market Revenue and Forecast, by End-use (2019-2030)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Product (2019-2030)
9.4.4.2. Market Revenue and Forecast, by End-use (2019-2030)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Product (2019-2030)
9.4.5.2. Market Revenue and Forecast, by End-use (2019-2030)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Product (2019-2030)
9.4.6.2. Market Revenue and Forecast, by End-use (2019-2030)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Product (2019-2030)
9.5.2. Market Revenue and Forecast, by End-use (2019-2030)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Product (2019-2030)
9.5.3.2. Market Revenue and Forecast, by End-use (2019-2030)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Product (2019-2030)
9.5.4.2. Market Revenue and Forecast, by End-use (2019-2030)
Chapter 10. Company Profiles
10.1. Alcon, Inc.
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Johnson and Johnson Vision Care, Inc.
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Bausch & Lomb Incorporated
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Carl Zeiss Meditec AG (ZEISS International)
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Rayner
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. EyeKon Medical, Inc.
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Lenstec, Inc.
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. HumanOptics AG
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. STAAR Surgical Company
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. HOYA CORPORATION
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms
Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/39136
Contact Us:
Vision Research Reports
Call: +1 9197 992 333
